These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18086182)

  • 1. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial.
    Hickman M; McDonald T; Judd A; Nichols T; Hope V; Skidmore S; Parry JV
    J Viral Hepat; 2008 Apr; 15(4):250-4. PubMed ID: 18086182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study.
    Seme K; Mocilnik T; Fujs K; Babic DZ; Todorović A; Fras-Stefan T; Poljak M
    J Virol Methods; 2007 Mar; 140(1-2):218-21. PubMed ID: 17157928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral RNA testing in hepatitis C antibody-positive veterans.
    Rongey CA; Kanwal F; Hoang T; Gifford AL; Asch SM
    Am J Prev Med; 2009 Mar; 36(3):235-8. PubMed ID: 19162434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random mandatory drugs testing of prisoners: a biassed means of gathering information.
    Gore SM; Bird AG; Strang JS
    J Epidemiol Biostat; 1999; 4(1):3-9. PubMed ID: 10613711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention.
    Cullen BL; Hutchinson SJ; Cameron SO; Anderson E; Ahmed S; Spence E; Mills PR; Mandeville R; Forrest E; Washington M; Wong R; Fox R; Goldberg DJ
    J Public Health (Oxf); 2012 Mar; 34(1):14-23. PubMed ID: 22138489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hepatitis C virus RNA in dried blood spots.
    Bennett S; Gunson RN; McAllister GE; Hutchinson SJ; Goldberg DJ; Cameron SO; Carman WF
    J Clin Virol; 2012 Jun; 54(2):106-9. PubMed ID: 22418454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of hepatitis C virus in syringes confiscated in prisons in Australia.
    Dolan K; Larney S; Jacka B; Rawlinson W
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1655-7. PubMed ID: 19788605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
    Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
    Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of hepatitis C virus testing methods among injecting drug users.
    White B; Day C; Thein HH; Doab A; Bates A; Holden J; van Beek I; Maher L
    Drug Alcohol Rev; 2008 Nov; 27(6):666-70. PubMed ID: 19378449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.
    Hickman M; Hope V; Brady T; Madden P; Jones S; Honor S; Holloway G; Ncube F; Parry J
    J Viral Hepat; 2007 Sep; 14(9):645-52. PubMed ID: 17697017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hepatitis C virus in the Dartmoor prison population: an observational study.
    Horne JA; Clements AJ; Drennan P; Stein K; Cramp ME
    J Public Health (Oxf); 2004 Dec; 26(4):372-5. PubMed ID: 15598857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit into blood-borne virus services in Her Majesty's Prison Service.
    Murray E; Jones D
    Int J STD AIDS; 2008 May; 19(5):347-8. PubMed ID: 18482968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study.
    Foucher J; Reiller B; Jullien V; Léal F; di Cesare ES; Merrouche W; Delile JM; de Lédinghen V
    J Viral Hepat; 2009 Feb; 16(2):121-31. PubMed ID: 19175876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
    Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
    J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand.
    Thongsawat S; Maneekarn N; Kuniholm MH; Pantip C; Thungsuputi A; Lumlertkul D; Bannachak D; Nelson KE
    J Med Virol; 2008 May; 80(5):808-15. PubMed ID: 18360894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.
    Craine N; Parry J; O'Toole J; D'Arcy S; Lyons M
    J Viral Hepat; 2009 Mar; 16(3):219-22. PubMed ID: 19175879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons.
    Craine N; Whitaker R; Perrett S; Zou L; Hickman M; Lyons M
    Eur J Public Health; 2015 Apr; 25(2):351-7. PubMed ID: 25061233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature.
    Coats JT; Dillon JF
    Int J Drug Policy; 2015 Nov; 26(11):1050-5. PubMed ID: 26118799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.